Sign in
4

Changes in Ownership

ANI PHARMACEUTICALS INC Filed Acc 0001871002-23-000009

SVP - CORP. DEV. & STRATEGY sold 20,000 shares at $56.48 ($1,129,600)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Gassert Chad SVP - CORP. DEV. & STRATEGY 2023-10-02 Sale 10b5-1 −20,000 $56.48 $1,129,600 293,226 I
Open-market sales · 20,000 sh · avg $56.48 · $1,129,600
Loading xslF345X05/wk-form4_1696377605.xml…